Dartmouth Researchers Engineer Drug Micro-factory to Attack Tumor
May 14, 2015 | NCCC
Dartmouth investigators, including professors Barjor Gimi and Karl Griswold, have engineered therapeutic cells inside nanoporous capsules to secrete antitumor molecules from within the tumor.
Food Dye, Near Infrared Light Can Aid in Breast Resection
May 12, 2015 | NCCC
Investigators at the Optics in Medicine Lab led by professors Brian Pogue and Keith Paulsen—with first author and PhD candidate David M. McClatchy III—devised a novel approach to help prevent cancerous tissue left behind due to unclear margins.
What Is Engineering? Learn About Engineering Through a MOOC
April 27, 2015 | The Huffington Post
A desire to help people of all ages, particularly K12 students, better understand engineering led me to develop a massive open online course, or MOOC.
Three Engineering Professors Selected for SYNERGY Translational Pilot Awards
April 17, 2015 | Dartmouth SYNERGY
The SYNERGY Translational Pilot Program facilitates collaborative translational research studies across Dartmouth and affiliated health centers and communities.
The Oprahs Of Biotech: People Who Can Go By First Name Only
April 10, 2015 | Forbes
Dartmouth engineering professor Tillman Gerngross has become of the few people in biotech who the insiders know by first name alone.
Dartmouth investigators led by Karl Griswold are engineering antibacterial enzymes to target the prevalent drug-resistant bacterium Staphylococcus aureus.
“Firefly” Mechanism Makes Cancer Studies More Efficient, Less Expensive
April 1, 2015 | NCCC
The mechanism that makes fireflies glow through a process called bioluminescence can be used to study tumor response to therapy as well.
New Faculty Bring Passion and Breadth of Knowledge
April 1, 2015 | Dartmouth Now
Dartmouth welcomes new faculty in the Arts and Sciences and professional schools this academic year including Dartmouth engineering professor John Zhang.
Researchers Use Nanoparticles to Selectively Target Tumor Cells in Two Cancer Models
March 25, 2015 | NCCC
Professor Karl Griswold: "The ultimate utility of anti-cancer nanoparticle technologies will depend in large part on their capacity to selectively home to cancer cells."
Immunomagnetic Assay On-a-Chip Captures, Analyzes Circulating Tumor Cells
March 24, 2015 | NCCC
Professor John Zhang led a team of bioengineers to find a new way to quantify rare tumor markers that allow oncologists to make prognoses and select therapies.